drugset / Trial / NCT06329661

A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine

NCT06329661

Phase 4 Completed 204 enrolled Novaliq GmbH
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this trial is to evaluate the effect of cyclosporine ophthalmic solution, 0.1% on corneal endothelial cell health in comparison to a hypotonic saline solution in subjects with Dry Eye Disease (DED)

Timeline

Start
2024-04-22
Primary completion
2025-07-30
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cyclosporine Peptide 0.1 % Other

Indications